Viewing Study NCT06219356


Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2025-12-25 @ 9:27 PM
Study NCT ID: NCT06219356
Status: RECRUITING
Last Update Posted: 2025-08-19
First Post: 2023-12-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas
Sponsor: Hangzhou GluBio Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module